Pacifico starts building 42 MW in Japan
Pacifico Energy has started building a 42 MW solar project in northeastern Japan.
Estonia’s utility Eesti Energia enters solar business
The company will offer solar leasing solutions as well as turn-key projects for self-consumption.
Interview: SunPower pivots to more conventional cell technologies and shingled cell modules
SunPower is famous for its back-contact cells, boasting one of the industry’s most advanced technologies. Josh Moore, SunPower Director, explains why the company is now ramping up 600 MW of production for different types of front-contact cells and shingled modules. He will pitch the advantages at pv magazine’s Future PV event to be held at SPI on Tuesday September 12.
UK CfD auction sees renewables set record-low strike price
Two offshore wind farms to be built for just £57.50 per MWh following today’s second Contracts for Difference subsidy auction – well below price government guaranteed for Hinkley Point C nuclear farm.
Panasonic to stop PV production at factory in Japan
Panasonic has decided to stop producing PV modules at a factory it owns near Kyoto, Japan.
Hevel Solar starts construction on 15 MW solar plant in south-western Russia
The plant is part of a 165 MW PV project pipeline that the company is developing in Russia’s Astrakhan region.
Mexico: 843 MW of solar submitted for environmental approval
The six projects are planned to be built in the states of Baja California, Sonora, Puebla and Chihuahua.
Scientists use light & humidity to ‘heal’ perovskite defects
A team of researchers from leading European and USA universities has discovered that defects in crystalline perovskite structures can be permanently healed through careful exposure to light and humidity.
LONGi Solar posts $191.2 million profit in H1
LONGi Solar Technology has recorded a net profit of CNY 1.236 billion ($191.2 million) for the first half of 2017, up 43.6% year on year.
Report: Trump likely to impose solar tariffs if USITC recommends them
According to Axios, officials close to the president put the likelihood of him imposing a remedy at 90%.
